Dangge Wang

5.6k total citations · 4 hit papers
53 papers, 4.9k citations indexed

About

Dangge Wang is a scholar working on Biomedical Engineering, Immunology and Biomaterials. According to data from OpenAlex, Dangge Wang has authored 53 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Biomedical Engineering, 25 papers in Immunology and 19 papers in Biomaterials. Recurrent topics in Dangge Wang's work include Nanoplatforms for cancer theranostics (34 papers), Nanoparticle-Based Drug Delivery (19 papers) and Immunotherapy and Immune Responses (18 papers). Dangge Wang is often cited by papers focused on Nanoplatforms for cancer theranostics (34 papers), Nanoparticle-Based Drug Delivery (19 papers) and Immunotherapy and Immune Responses (18 papers). Dangge Wang collaborates with scholars based in China, Norway and Switzerland. Dangge Wang's co-authors include Yaping Li, Haijun Yu, Bing Feng, Fangyuan Zhou, Lei Zhou, Zhiwen Zhang, Tingting Wang, Yuting Ma, Qi Yin and Tingting Wang and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Dangge Wang

52 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor Microenvironment‐Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade

2019 457 citations Fangyuan Zhou, Bing Feng et al. Advanced Materials profile →
Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment

2018 404 citations Bing Feng, Fangyuan Zhou et al. Advanced Materials profile →
Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy

2016 376 citations Dangge Wang, Tingting Wang et al. profile →
A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors

2018 355 citations Tingting Wang, Dangge Wang et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dangge Wang China	31	3.4k	1.6k	1.5k	1.5k	928	53	4.9k
Song Shen China	39	2.4k 0.7×	1.6k 0.9×	2.2k 1.4×	1.2k 0.8×	556 0.6×	82	5.0k
Kun Shao China	36	3.0k 0.9×	1.2k 0.7×	2.1k 1.3×	638 0.4×	1.5k 1.6×	75	5.3k
Xuexiang Han China	42	2.1k 0.6×	1.2k 0.7×	2.6k 1.7×	840 0.6×	1.0k 1.1×	64	5.4k
Christina Chan United States	20	3.2k 0.9×	841 0.5×	948 0.6×	1.3k 0.9×	1.1k 1.2×	22	4.3k
Weijing Yang China	37	2.5k 0.7×	1.3k 0.8×	1.4k 0.9×	792 0.5×	995 1.1×	69	4.1k
Mingbin Zheng China	37	5.4k 1.6×	2.2k 1.4×	1.9k 1.2×	629 0.4×	1.8k 1.9×	77	6.8k
Venkata Ramana Kotamraju United States	36	2.2k 0.7×	2.3k 1.4×	3.7k 2.4×	857 0.6×	665 0.7×	51	6.4k
Lin‐Lin Bu China	37	2.5k 0.7×	1.5k 0.9×	2.4k 1.6×	1.6k 1.1×	450 0.5×	128	5.8k
Ju Hee Ryu South Korea	35	2.5k 0.7×	1.7k 1.0×	2.3k 1.5×	387 0.3×	1.1k 1.2×	72	5.2k
Xinyu He China	23	2.0k 0.6×	1.3k 0.8×	1.1k 0.7×	453 0.3×	643 0.7×	64	3.2k

Countries citing papers authored by Dangge Wang

Since Specialization

Citations

This map shows the geographic impact of Dangge Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dangge Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dangge Wang more than expected).

Fields of papers citing papers by Dangge Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dangge Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dangge Wang. The network helps show where Dangge Wang may publish in the future.

Co-authorship network of co-authors of Dangge Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Dangge Wang. A scholar is included among the top collaborators of Dangge Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dangge Wang. Dangge Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shan, Xiaoting, Ying Cai, Xujie Sun, et al.. (2025). Computer‐Aided Design of Self‐Assembled Nanoparticles to Enhance Cancer Chemoimmunotherapy via Dual‐Modulation Strategy. Advanced Healthcare Materials. 14(7). e2404261–e2404261. 3 indexed citations

Yan, Dan, et al.. (2025). A Dendritic Cell‐Nanogel Conjugate for Tumor‐Draining Lymph Node‐Specific PD‐L1 Blockade. Advanced Materials. 37(39). e2504733–e2504733. 1 indexed citations

Xu, Xiaoxuan, et al.. (2025). Dendritic cell-liposome conjugates reverse immunosuppressive tumor microenvironment for inhibiting colitis-associated colorectal cancer. Acta Pharmacologica Sinica. 47(2). 444–455.

Wang, Jue, Xiangshi Sun, B. Zhao, et al.. (2024). Confined copper depletion via a hydrogel platform for reversing dabrafenib/cetuximab resistance in BRAFV600E-mutant colorectal cancer. Journal of Controlled Release. 375. 643–653. 3 indexed citations

Shan, Xiaoting, Ying Cai, Lingli Zhou, et al.. (2024). Rational strategies for improving the efficiency of design and discovery of nanomedicines. Nature Communications. 15(1). 9990–9990. 24 indexed citations

Yan, Dan, et al.. (2023). Smart drug delivery systems to overcome drug resistance in cancer immunotherapy. Cancer Biology and Medicine. 20(4). 248–267. 16 indexed citations

Zhang, Xinyue, Jie Li, Rong Rong, et al.. (2023). Enhancing the oral bioavailability of poorly water-soluble amisupiride with solid nanodispersion. Journal of Drug Delivery Science and Technology. 86. 104635–104635. 6 indexed citations

Zhou, Lei, Zehong Zhang, Xiaoting Shan, et al.. (2023). STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy. National Science Review. 10(10). nwad214–nwad214. 30 indexed citations

Zhao, Zitong, Jue Wang, Lei Fang, et al.. (2022). Dual-responsive nanoparticles loading bevacizumab and gefitinib for molecular targeted therapy against non-small cell lung cancer. Acta Pharmacologica Sinica. 44(1). 244–254. 9 indexed citations

10.

Xiao, Ping, Xiaochen Liu, Zitong Zhao, et al.. (2022). Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry. Signal Transduction and Targeted Therapy. 7(1). 386–386. 92 indexed citations

11.

Zhao, Zitong, Lei Fang, Ping Xiao, et al.. (2022). Walking Dead Tumor Cells for Targeted Drug Delivery Against Lung Metastasis of Triple‐Negative Breast Cancer. Advanced Materials. 34(33). e2205462–e2205462. 73 indexed citations

12.

Fang, Lei, Zitong Zhao, Jue Wang, et al.. (2021). Light-controllable charge-reversal nanoparticles with polyinosinic-polycytidylic acid for enhancing immunotherapy of triple negative breast cancer. Acta Pharmaceutica Sinica B. 12(1). 353–363. 39 indexed citations

13.

Wang, Tingting, Dangge Wang, Haijun Yu, et al.. (2018). A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors. Nature Communications. 9(1). 1532–1532. 355 indexed citations breakdown →

14.

Liu, Jianping, Tingting Wang, Dangge Wang, et al.. (2016). Smart nanoparticles improve therapy for drug-resistant tumors by overcoming pathophysiological barriers. Acta Pharmacologica Sinica. 38(1). 1–8. 59 indexed citations

15.

Zhou, Fangyuan, Bing Feng, Haijun Yu, et al.. (2016). Cisplatin Prodrug-Conjugated Gold Nanocluster for Fluorescence Imaging and Targeted Therapy of the Breast Cancer. Theranostics. 6(5). 679–687. 108 indexed citations

16.

Feng, Bing, Zhiai Xu, Fangyuan Zhou, et al.. (2015). Near infrared light-actuated gold nanorods with cisplatin–polypeptide wrapping for targeted therapy of triple negative breast cancer. Nanoscale. 7(36). 14854–14864. 52 indexed citations

17.

Yu, Haijun, Chengyue Guo, Bing Feng, et al.. (2015). Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer. Theranostics. 6(1). 14–27. 87 indexed citations

18.

Wang, Dangge, Zhiai Xu, Haijun Yu, et al.. (2014). Treatment of metastatic breast cancer by combination of chemotherapy and photothermal ablation using doxorubicin-loaded DNA wrapped gold nanorods. Biomaterials. 35(29). 8374–8384. 143 indexed citations

19.

Shen, Shun, Hongyan Tang, Xiaotong Zhang, et al.. (2013). Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation. Biomaterials. 34(12). 3150–3158. 321 indexed citations

20.

Ren, Jinfeng, Shun Shen, Dangge Wang, et al.. (2012). The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. Biomaterials. 33(11). 3324–3333. 321 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact